NYSE:SYK Stryker (SYK) Stock Price, News & Analysis $359.76 -1.55 (-0.43%) (As of 10/17/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends About Stryker Stock (NYSE:SYK) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Stryker alerts:Sign Up Key Stats Today's Range$359.04▼$364.0050-Day Range$325.20▼$371.9752-Week Range$255.22▼$374.63Volume820,703 shsAverage Volume1.25 million shsMarket Capitalization$137.05 billionP/E Ratio40.11Dividend Yield0.89%Price Target$381.16Consensus RatingModerate Buy Company OverviewStryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.Read More… Musk’s new company could top a trillion? (Ad)The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840. Click here to see the details because there’s not much time to prepare. Stryker Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks96th Percentile Overall ScoreSYK MarketRank™: Stryker scored higher than 96% of companies evaluated by MarketBeat, and ranked 66th out of 1,012 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.4 / 5Analyst RatingModerate Buy Consensus RatingStryker has received a consensus rating of Moderate Buy. The company's average rating score is 2.79, and is based on 15 buy ratings, 4 hold ratings, and no sell ratings.Amount of Analyst CoverageStryker has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Stryker's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth12.08% Earnings GrowthEarnings for Stryker are expected to grow by 12.08% in the coming year, from $12.00 to $13.45 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Stryker is 40.11, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 133.32.Price to Earnings Ratio vs. SectorThe P/E ratio of Stryker is 40.11, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 139.15.Price to Earnings Growth RatioStryker has a PEG Ratio of 2.78. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioStryker has a P/B Ratio of 7.35. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Stryker's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted1.42% of the float of Stryker has been sold short.Short Interest Ratio / Days to CoverStryker has a short interest ratio ("days to cover") of 4.2.Change versus previous monthShort interest in Stryker has recently increased by 19.20%, indicating that investor sentiment is decreasing significantly. Dividend3.3 / 5Dividend StrengthStrong Dividend YieldStryker has a dividend yield of 0.89%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthStryker has been increasing its dividend for 31 years.Dividend CoverageThe dividend payout ratio of Stryker is 36.53%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Stryker will have a dividend payout ratio of 23.79% next year. This indicates that Stryker will be able to sustain or increase its dividend.Read more about Stryker's dividend. Sustainability and ESG4.2 / 5Environmental Score-0.95 Percentage of Shares Shorted1.42% of the float of Stryker has been sold short.Short Interest Ratio / Days to CoverStryker has a short interest ratio ("days to cover") of 4.2.Change versus previous monthShort interest in Stryker has recently increased by 19.20%, indicating that investor sentiment is decreasing significantly. News and Social Media3.0 / 5News Sentiment0.47 News SentimentStryker has a news sentiment score of 0.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.71 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 18 news articles for Stryker this week, compared to 12 articles on an average week.Search Interest11 people have searched for SYK on MarketBeat in the last 30 days. This is an increase of 10% compared to the previous 30 days.MarketBeat Follows9 people have added Stryker to their MarketBeat watchlist in the last 30 days. This is an increase of 125% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Stryker insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $71,811,372.00 in company stock.Percentage Held by InsidersOnly 5.90% of the stock of Stryker is held by insiders.Percentage Held by Institutions77.09% of the stock of Stryker is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Stryker's insider trading history. Receive SYK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Stryker and its competitors with MarketBeat's FREE daily newsletter. Email Address SYK Stock News HeadlinesStryker’s Acquisition Spree: Double-Digit Growth on the HorizonStryker has acquired several firms over the last few months, including one related to AI. Do these purchases make the stock a buy?October 10, 2024 | marketbeat.comInsider Selling: Stryker Co. (NYSE:SYK) VP Sells 2,121 Shares of StockSeptember 18, 2024 | insidertrades.comElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.October 17, 2024 | Porter & Company (Ad)Stryker Co. (NYSE:SYK) VP Sells $2,696,202.06 in StockSeptember 18, 2024 | insidertrades.comBoston Scientific: Why This MedTech Giant Isn’t Slowing Down (SYK)Boston Scientific Co (NYSE: BSX) is a global medical device manufacturer that’s seeing a strong influx of investors as shares grind to new all-time highs.September 17, 2024 | marketbeat.comHere’s What Leonardo DRS’ Laser-Equipped Counter-Drone Stryker Armored Vehicle Is Capable OfOctober 16 at 10:28 PM | news.yahoo.comLeonardo DRS Gives Details On Its Directed-Energy Counter-Drone StrykerOctober 16 at 5:27 PM | yahoo.comIs Stryker Corporation's (NYSE:SYK) Recent Performance Tethered To Its Attractive Financial Prospects?October 16 at 12:25 PM | finance.yahoo.comSee More Headlines SYK Stock Analysis - Frequently Asked Questions How have SYK shares performed this year? Stryker's stock was trading at $299.46 at the start of the year. Since then, SYK shares have increased by 20.1% and is now trading at $359.76. View the best growth stocks for 2024 here. How were Stryker's earnings last quarter? Stryker Co. (NYSE:SYK) announced its quarterly earnings data on Tuesday, July, 30th. The medical technology company reported $2.81 earnings per share for the quarter, topping the consensus estimate of $2.79 by $0.02. The firm's revenue was up 8.5% on a year-over-year basis. Read the conference call transcript. Does Stryker have any subsidiaries? Stryker subsidiaries include these companies: Vocera Communications, Vocera, Gauss Surgical, OrthoSensor, Wright Medical Group, Cardan Robotics, Mobius Imaging, and others. Who are Stryker's major shareholders? Stryker's top institutional investors include Handelsbanken Fonder AB (0.05%), Chesley Taft & Associates LLC (0.04%), Bath Savings Trust Co (0.03%) and Carnegie Investment Counsel (0.03%). Insiders that own company stock include Ronda E Stryker, Kevin Lobo, James Andrew Pierce, Allan C Golston, M Kathryn Fink, Viju Menon, Robert S Fletcher, Srikant M Datar, William E Berry Jr and Glenn S Boehnlein. View institutional ownership trends. How do I buy shares of Stryker? Shares of SYK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Stryker own? Based on aggregate information from My MarketBeat watchlists, some other companies that Stryker investors own include Broadcom (AVGO), ServiceNow (NOW), BlackRock (BLK), NVIDIA (NVDA), Meta Platforms (META), UnitedHealth Group (UNH) and Advanced Micro Devices (AMD). Company Calendar Ex-Dividend for 7/31 Dividend6/28/2024Last Earnings7/30/2024Dividend Payable7/31/2024Ex-Dividend for 10/31 Dividend9/30/2024Today10/17/2024Next Earnings (Confirmed)10/29/2024Dividend Payable10/31/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & medical instruments Sub-IndustryHealth Care Equipment Current SymbolNYSE:SYK CUSIP86366710 CIK310764 Webwww.strykercorp.com Phone(269) 385-2600Fax269-385-1062Employees52,000Year Founded1941Price Target and Rating Average Stock Price Target$381.16 High Stock Price Target$406.00 Low Stock Price Target$350.00 Potential Upside/Downside+6.0%Consensus RatingModerate Buy Rating Score (0-4)2.79 Research Coverage19 Analysts Profitability EPS (Most Recent Fiscal Year)$8.76 Trailing P/E Ratio40.10 Forward P/E Ratio29.98 P/E Growth2.78Net Income$3.17 billion Net Margins16.12% Pretax Margin18.78% Return on Equity22.89% Return on Assets11.03% Debt Debt-to-Equity Ratio0.51 Current Ratio1.68 Quick Ratio0.95 Sales & Book Value Annual Sales$21.39 billion Price / Sales6.41 Cash Flow$13.41 per share Price / Cash Flow26.83 Book Value$48.94 per share Price / Book7.35Miscellaneous Outstanding Shares380,950,000Free Float360,116,000Market Cap$137.04 billion OptionableOptionable Beta0.91 Social Links 2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (NYSE:SYK) was last updated on 10/17/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredRetire off just one stock ticker?ONE AI Stock is All You Need... There are over 6,000 stocks listed in the market right now. They will NOT m...Behind the Markets | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredAdd $2T of Potential Magic to Your PortfolioRevolutionizing a whole $2T entertainment and licensing industry might sound like the stuff of fairytales. But...Elf Labs | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMassive trading opportunity begins by October 21 October 21 could spark a mania among “next-generation” AI stocks. That’s the newest prediction from a Wall Str...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stryker Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Stryker With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.